| 1. |
Eiji Iwama, Education for oncologists, pulmonologists, and physician scientists in Japan, 第21回日本臨床腫瘍学会学術集会, 2024.02. |
| 2. |
Atsushi Shimauchi, Hirono Tsutsumi, Eiji Iwama, Daisuke Shibahara, Yasuto Yoneshima, Kentaro Tanaka, Isamu Okamoto
, Investigation of dimer formation and intracellular dynamics of HER2 in HER2 mutation-positive lung cancer, 第82回日本癌学会学術集会, 2023.09. |
| 3. |
Ritsu Ibusuki, Eiji Iwama, Hirono Tsutsumi, Daisuke Shibahara, Yasuto Yoneshima, Kentaro Tanaka, Isamu Okamoto, TP53 gain-of-function mutations promote
osimertinib resistance via TNF-α–NF-κB signaling
, 第82回日本癌学会学術集会, 2023.09. |
| 4. |
Eiji Iwama, ALK rearranged NSCLC; what's the best sequence?, 第61回日本肺癌学会学術集会, 2020.11. |
| 5. |
Eiji Iwama, Kazuko Sakai, Koichi Azuma, Daijiro Harada, Kaname Nosaki, Katsuyuki Hotta, Makoto Nishio, Takayasu Kurata, Tatsuro Fukuhara, Hiroaki Akamatsu, Koichi Goto, Takayuki Shimose, Junji Kishimoto, Yoichi Nakanishi, Kazuto Nishio and Isamu Okamoto, A Multicenter Prospective Biomarker Study to Explore Mechanisms of Afatinib Resistance Based on Digital PCR and Next Generation Sequencing, World Conference on Lung Cancer 2018, 2018.09. |
| 6. |
Eiji Iwama, Highly sensitive detection of EGFR mutations in non-small cell lung cancer （International Symposium）, 第56回日本呼吸器学会学術講演会, 2016.04. |
| 7. |
Eiji Iwama, Kazuko Sakai, Koichi Azuma, Kaname Nosaki, Daijiro Harada5, Katsuyuki Hotta, Fumiyoshi Ohyanagi, Takayasu Kurata, Hiroaki Akamatsu, Koichi Goto, Tatsuro Fukuhara, Yoichi Nakanishi, Kazuto Nishio, Isamu Okamoto, A multicenter prospective biomarker study in afatinib-treated patients with EGFR-mutation positive non-small cell lung cancer, ESMO Asia 2015, 2015.12. |
| 8. |
Iwama Eiji, Digital PCR for Detecting Genetic Mutations, 2014 Inha University Hospital International Symposium –Recent Developments in Healthcare Researches for Patients, 2014.06. |
| 9. |
Iwama Eiji, Highly sensitive and quantitative detection of EGFR T790M mutation in tumor samples by nanofluidic digital PCR, 50th American Society of Clinical Oncology (ASCO), 2014.05. |
| 10. |
Iwama Eiji, Which doNSCLC patients with EGFR mutation prefer as a first line therapy, EGFR-TKI or chemotherapy ? A vignettes study (LOGiK0903)
, 18th Congress of the Asian Pacific Society of Respirology, 2013.11. |
| 11. |
Iwama Eiji, Carcinogenesis of primary lung cancer adjoining pulmonary bulla is closely associated with smoking.
, 5th APLCC（5th Asia Pacific Lung Cancer Conference）, 2012.11. |
